Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
Purpose: The purpose of this study is to evaluate the efficacy and safety of treatment with
trastuzumab (Herceptin) along with the three other chemotherapy drugs, paclitaxel,
carboplatin and gemcitabine, in patients who have advanced urothelial cancer. This clinical
trial will also collect information (alternative therapy, response rates, overall survival)
from enrolled patients with HER2 negative tumors who are ineligible to receive study
treatment.
Phase:
Phase 2
Details
Lead Sponsor:
University of Michigan Cancer Center University of Michigan Rogel Cancer Center